Chris Molloy

ID Business Solutions Ltd. provides business software solutions. The company was founded by Neil Kipling in 1989 and is headquartered in Guildford, the United Kingdom.

NorthWest EHealth Ltd. is a British company that champions the transformation of patient lives by trialling innovative therapies with those who need it most. The company is based in Manchester, UK. The company provides the pharmaceutical industry with an alternative approach for clinical trial design and management in order to safely accelerate drug development. The company was founded in 2008. The CEO is Martin Gibson.

ID Business Solutions Ltd. provides business software solutions. The company was founded by Neil Kipling in 1989 and is headquartered in Guildford, the United Kingdom.

NorthWest EHealth Ltd. is a British company that champions the transformation of patient lives by trialling innovative therapies with those who need it most. The company is based in Manchester, UK. The company provides the pharmaceutical industry with an alternative approach for clinical trial design and management in order to safely accelerate drug development. The company was founded in 2008. The CEO is Martin Gibson.

NorthWest EHealth Ltd. is a British company that champions the transformation of patient lives by trialling innovative therapies with those who need it most. The company is based in Manchester, UK. The company provides the pharmaceutical industry with an alternative approach for clinical trial design and management in order to safely accelerate drug development. The company was founded in 2008. The CEO is Martin Gibson.

Medicines Discovery Catapult Ltd. is a not-for-profit organization that enables the community to accelerate innovative drug discovery. The private company is based in Macclesfield, UK, and has subsidiaries in the United Kingdom. The British company focuses on pioneering the next generation of medicine discovery techniques and technologies by validating new ways of discovering medicines and driving key talent and expertise across the sector. The CEO of the company is Chris Molloy.

Medicines Discovery Catapult Ltd. is a not-for-profit organization that enables the community to accelerate innovative drug discovery. The private company is based in Macclesfield, UK, and has subsidiaries in the United Kingdom. The British company focuses on pioneering the next generation of medicine discovery techniques and technologies by validating new ways of discovering medicines and driving key talent and expertise across the sector. The CEO of the company is Chris Molloy.

Medicines Discovery Catapult Ltd. is a not-for-profit organization that enables the community to accelerate innovative drug discovery. The private company is based in Macclesfield, UK, and has subsidiaries in the United Kingdom. The British company focuses on pioneering the next generation of medicine discovery techniques and technologies by validating new ways of discovering medicines and driving key talent and expertise across the sector. The CEO of the company is Chris Molloy.

Medicines Discovery Catapult Ltd. is a not-for-profit organization that enables the community to accelerate innovative drug discovery. The private company is based in Macclesfield, UK, and has subsidiaries in the United Kingdom. The British company focuses on pioneering the next generation of medicine discovery techniques and technologies by validating new ways of discovering medicines and driving key talent and expertise across the sector. The CEO of the company is Chris Molloy.

Medicines Discovery Catapult Ltd. is a not-for-profit organization that enables the community to accelerate innovative drug discovery. The private company is based in Macclesfield, UK, and has subsidiaries in the United Kingdom. The British company focuses on pioneering the next generation of medicine discovery techniques and technologies by validating new ways of discovering medicines and driving key talent and expertise across the sector. The CEO of the company is Chris Molloy.

Medicines Discovery Catapult Ltd. is a not-for-profit organization that enables the community to accelerate innovative drug discovery. The private company is based in Macclesfield, UK, and has subsidiaries in the United Kingdom. The British company focuses on pioneering the next generation of medicine discovery techniques and technologies by validating new ways of discovering medicines and driving key talent and expertise across the sector. The CEO of the company is Chris Molloy.

NorthWest EHealth Ltd. is a British company that champions the transformation of patient lives by trialling innovative therapies with those who need it most. The company is based in Manchester, UK. The company provides the pharmaceutical industry with an alternative approach for clinical trial design and management in order to safely accelerate drug development. The company was founded in 2008. The CEO is Martin Gibson.

Medicines Discovery Catapult Ltd. is a not-for-profit organization that enables the community to accelerate innovative drug discovery. The private company is based in Macclesfield, UK, and has subsidiaries in the United Kingdom. The British company focuses on pioneering the next generation of medicine discovery techniques and technologies by validating new ways of discovering medicines and driving key talent and expertise across the sector. The CEO of the company is Chris Molloy.

Medicines Discovery Catapult Ltd. is a not-for-profit organization that enables the community to accelerate innovative drug discovery. The private company is based in Macclesfield, UK, and has subsidiaries in the United Kingdom. The British company focuses on pioneering the next generation of medicine discovery techniques and technologies by validating new ways of discovering medicines and driving key talent and expertise across the sector. The CEO of the company is Chris Molloy.

Medicines Discovery Catapult Ltd. is a not-for-profit organization that enables the community to accelerate innovative drug discovery. The private company is based in Macclesfield, UK, and has subsidiaries in the United Kingdom. The British company focuses on pioneering the next generation of medicine discovery techniques and technologies by validating new ways of discovering medicines and driving key talent and expertise across the sector. The CEO of the company is Chris Molloy.

ID Business Solutions Ltd. provides business software solutions. The company was founded by Neil Kipling in 1989 and is headquartered in Guildford, the United Kingdom.